Effects of Omega 3 in Hemodialysis Patients

Laboratoire Régional de Nutrition Humaine

Status: Completed

Conditions: Hemodialysis; End Stage Renal Disease

Treatments: Behavioral: fish oil supplementation

Study type: Interventional

Funder types: Other

Identifiers

NCT00431899

HDW3

Details and patient eligibility

About

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• hemodialysis at least 6 months duration end stage renal disease

Exclusion criteria

• • Age < 18 y ou > 75 y
• Hemodialysis < 6 months
• Diabetes, obesity
• allergy to fish
• Asthma
• glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin
• erythropoïetin < 3 months
• Cancer
• Hemoglobin < 11 g/l
• disease < 1 month
• pregnancy
• respiratory insufficiency
• intensive sport practice
• refusal

Trial design

Primary purpose: Screening

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)